Compare HLX & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HLX | PRCT |
|---|---|---|
| Founded | 1979 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 1996 | 2021 |
| Metric | HLX | PRCT |
|---|---|---|
| Price | $9.79 | $26.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | $10.50 | ★ $35.44 |
| AVG Volume (30 Days) | 2.0M | ★ 2.1M |
| Earning Date | 04-22-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1.71 |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $876,561,000.00 | $308,054,000.00 |
| Revenue This Year | $2.91 | $31.62 |
| Revenue Next Year | $4.97 | $24.45 |
| P/E Ratio | $45.62 | ★ N/A |
| Revenue Growth | 3.60 | ★ 37.22 |
| 52 Week Low | $5.52 | $19.35 |
| 52 Week High | $10.75 | $64.89 |
| Indicator | HLX | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 63.18 | 47.03 |
| Support Level | $6.20 | $19.35 |
| Resistance Level | $10.75 | $29.24 |
| Average True Range (ATR) | 0.33 | 1.62 |
| MACD | 0.02 | 0.15 |
| Stochastic Oscillator | 95.31 | 55.16 |
Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. The Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S., and it also has its presence in North Sea, Brazil, Asia Pacific, West Africa, and Other.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.